ADVERTISEMENT

TCS Q2 Results Review: Dolat Capital Upgrades Rating To 'Add' But Trims Target Price — Here's Why

Dolat Capital revises TCS' rating to ‘Accumulate’ from Reduce, sees upto 10% potential upside

<div class="paragraphs"><p>TCS reported a strong TCV of $10 billion, 16% YoY, led by a mega-deal with TRIB Insurance that highlights successful vendor consolidation opportunities.</p><p> (Photo Source: Company's official Facebook page)</p></div>
TCS reported a strong TCV of $10 billion, 16% YoY, led by a mega-deal with TRIB Insurance that highlights successful vendor consolidation opportunities.

(Photo Source: Company's official Facebook page)

Noting commentary on a sustained weak macro environment, TCS' growth visibility remains low. Despite robust deal wins and TCV pipeline, its conversion into growth remains to be seen while margins remain healthy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit